Quick Answer
SELLAS Life Sciences Group, Inc. reported Cash And Cash Equivalents At Carrying Value of $71.79 million for the year ending 2025.
- SELLAS Life Sciences Group, Inc. showed an increase of +417.0% in Cash And Cash Equivalents At Carrying Value from 2024 to 2025.
- This data is from SELLAS Life Sciences Group, Inc.'s annual report (Form 10-K), filed with the SEC on March 19, 2026.
- XBRL data for this metric is available from 2009 to 2025 (17 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 17 years of available data (2009 to 2025), SELLAS Life Sciences Group, Inc.'s Cash And Cash Equivalents At Carrying Value has grown by 1,163.1%.
- Historical annual values: Fiscal year 2025: $71.79 million | Fiscal year 2024: $13.89 million | Fiscal year 2023: $2.53 million | Fiscal year 2022: $17.13 million | Fiscal year 2021: $21.36 million | Fiscal year 2020: $35.30 million | Fiscal year 2019: $7.28 million | Fiscal year 2018: $5.34 million | Fiscal year 2017: $2.32 million | Fiscal year 2016: $5.96 million | Fiscal year 2015: $1.40 million | Fiscal year 2014: $23.65 million | Fiscal year 2013: $47.79 million | Fiscal year 2012: $32.81 million | Fiscal year 2011: $47.79 million | Fiscal year 2010: $6.89 million | Fiscal year 2009: $5.68 million.
- Data sourced from SEC EDGAR public filings as of June 23, 2026.
Last verified: